Avia Pharma are happy to announce that we have further deepen our relationship with Perrigo to include Dentosal, a much appreciated tooth paste, on the Nordic market.
The pharmaceutical company Avia Pharma has acquired the Swedish pharmaceutical company Pharmaprim, with a product portfolio consisting of drugs in urology, rheumatology and endocrinology.
On December 31, 2019, Avia Pharma acquired the rights to ACO Karbamid and ACO Glycerol from Perrigo.
Following a strong sales increase in the current portfolio, Viiral AS have trusted Avia Pharma to launch Viiral on the Nordic market.
With a strong foot print in women’s health Avia Pharma are trusted to launch Femarelle in Finland.
Following a strong sales increase in the current portfolio, Avia Pharma and Perrigo have deepened the relationship to also include Vectavir®, Vectatone®, Oralmedic® and Predictor®.
Avia Pharma has signed a long-term license agreement with Endoceutics for the Nordic commercial rights to Intrarosa®.
Avia Pharma appoints Mattias Wik as Business Unit Director Oncology/Urology.
Currently there are two Vitamin D drops being sold on the Swedish market. ACO Vitamin D drops does not contain palm oil but the competing product does.
Following a very strong sales increase for all products, Omega Pharma and Avia Pharma has decided to expand their co-operation.